Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Kintor Pharmaceutical Ltd ( (HK:9939) ) has provided an update.
Kintor Pharmaceutical Limited announced that all proposed resolutions at their Annual General Meeting (AGM) on June 10, 2025, were passed by shareholders via poll. The AGM saw the re-election of several directors and the re-appointment of PricewaterhouseCoopers as the company’s auditor. This successful AGM reflects the company’s stable governance and continued commitment to its strategic goals, positively impacting its stakeholders and reinforcing its position in the pharmaceutical industry.
More about Kintor Pharmaceutical Ltd
Kintor Pharmaceutical Limited is a company incorporated in the Cayman Islands, operating within the pharmaceutical industry. It focuses on developing and commercializing innovative therapies for unmet medical needs, with a market focus on providing solutions in the healthcare sector.
Average Trading Volume: 3,614,295
Technical Sentiment Signal: Buy
Current Market Cap: HK$638.4M
Find detailed analytics on 9939 stock on TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue